Literature DB >> 25472967

Reproductive issues in sickle cell disease.

Kim Smith-Whitley1.   

Abstract

As medical advances improve survival, reduce disease-related morbidity, and improve quality of life, reproductive issues will take higher priority in the sickle cell disease (SCD) community. A wide variety of topics are addressed in this chapter, including fertility, gonadal failure, erectile dysfunction, and menstrual issues in SCD. Etiologies of impaired male fertility are multifactorial and include hypogonadism, erectile dysfunction, sperm abnormalities, and complications of medical therapies. Much less is known about the prevalence and etiology of infertility in women with SCD. Other reproductive issues in women included in this review are pain and the menstrual cycle, contraception, and preconception counseling. Finally, long-term therapies for SCD and their impact on fertility are presented. Transfusional iron overload and gonadal failure are addressed, followed by options for fertility preservation after stem cell transplantation. Focus is placed on hydroxyurea therapy given its benefits and increasing use in SCD. The impact of this agent on spermatogenesis, azoospermia, and the developing fetus is discussed.
© 2014 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25472967     DOI: 10.1182/blood-2014-07-577619

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Reproductive Health CHOICES for Young Adults with Sickle Cell Disease or Trait: Randomized Controlled Trial Outcomes over Two Years.

Authors:  Agatha M Gallo; Diana J Wilkie; Yingwei Yao; Robert E Molokie; Christiane Stahl; Patricia E Hershberger; Zhongsheng Zhao; Marie L Suarez; Bonnye Johnson; Rigoberto Angulo; Jesus Carrasco; Veronica Angulo; Alexis A Thompson
Journal:  J Genet Couns       Date:  2015-08-28       Impact factor: 2.537

2.  Is low dose hydroxyurea the solution to the global epidemic of sickle cell disease?

Authors:  John J Strouse
Journal:  Pediatr Blood Cancer       Date:  2015-03-08       Impact factor: 3.167

Review 3.  Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease.

Authors:  Satheesh Chonat; Charles T Quinn
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  The hepatocyte-specific HNF4α/miR-122 pathway contributes to iron overload-mediated hepatic inflammation.

Authors:  Min Li; Yuxiao Tang; Lusha Wu; Fengfeng Mo; Xin Wang; Hongxia Li; Ruirui Qi; Hongwei Zhang; Arun Srivastava; Chen Ling
Journal:  Blood       Date:  2017-06-27       Impact factor: 22.113

Review 5.  A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.

Authors:  Gift D Pule; Shaheen Mowla; Nicolas Novitzky; Charles S Wiysonge; Ambroise Wonkam
Journal:  Expert Rev Hematol       Date:  2015-09-01       Impact factor: 2.819

Review 6.  Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerations.

Authors:  Monica Bhatia; Sujit Sheth
Journal:  J Blood Med       Date:  2015-07-10

7.  TSPO ligand FGIN-1-27 controls priapism in sickle cell mice via endogenous testosterone production.

Authors:  Biljana Musicki; Serkan Karakus; Justin D La Favor; Haolin Chen; Fabio H Silva; Mikael Sturny; Barry R Zirkin; Arthur L Burnett
Journal:  J Cell Physiol       Date:  2020-09-24       Impact factor: 6.384

8.  Provider Attitudes, Preferences, and Practices Regarding Sexual and Reproductive Health for Adolescents and Young Adults With Sickle Cell Disease.

Authors:  Maayan Leroy-Melamed; Seethal Jacob; Marcia L Shew; Traci M Kazmerski
Journal:  J Adolesc Health       Date:  2021-07-20       Impact factor: 5.012

Review 9.  Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease.

Authors:  Lydia H Pecker; Deva Sharma; Alecia Nero; Michael J Paidas; Russell E Ware; Andra H James; Kim Smith-Whitley
Journal:  Br J Haematol       Date:  2021-07-07       Impact factor: 8.615

10.  G6PD Deficiency and Hemoglobinopathies: Molecular Epidemiological Characteristics and Healthy Effects on Malaria Endemic Bioko Island, Equatorial Guinea.

Authors:  Min Lin; Li Ye Yang; Dong De Xie; Jiang Tao Chen; Santiago-m Monte Nguba; Carlos Sala Ehapo; Xiao Fen Zhan; Juan Urbano Monsuy Eyi; Rocio Apicante Matesa; Maximo Miko Ondo Obono; Hui Yang; Hui Tian Yang; Ji Dong Cheng
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.